Literature DB >> 11027361

RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.

R Baron1, E Fourcade, I Lajoie-Mazenc, C Allal, B Couderc, R Barbaras, G Favre, J C Faye, A Pradines.   

Abstract

Protein isoprenylation is a lipid posttranslational modification required for the function of many proteins that share a carboxyl-terminal CAAX motif. The X residue determines which isoprenoid will be added to the cysteine. When X is a methionine or serine, the farnesyl-transferase transfers a farnesyl, and when X is a leucine or isoleucine, the geranygeranyl-transferase I, a geranylgeranyl group. But despite its CKVL motif, RhoB was reported to be both geranylgeranylated and farnesylated. Thus, the determinants of RhoB prenylation appear more complex than initially thought. To determine the role of RhoB CAAX motif, we designed RhoB mutants with modified CAAX sequence expressed in baculovirus-infected insect cells. We demonstrated that RhoB was prenylated as a function of the three terminal amino acids, i.e., RhoB bearing the CAIM motif of lamin B or CLLL motif of Rap1A was farnesylated or geranylgeranylated, respectively. Next, we produced a specific polyclonal antibody against farnesyl cysteine methyl ester allowing prenylation analysis avoiding the metabolic labeling restrictions. We confirmed that the unique modification of the RhoB CAAX box was sufficient to direct the RhoB distinct prenylation in mammalian cells and, inversely, that a RhoA-CKVL chimera could be alternatively prenylated. Moreover, the immunoprecipitation of endogenous RhoB from cells with the anti-farnesyl cysteine antibody suggested that wild-type RhoB is farnesylated in vivo. Taken together, our results demonstrated that the three last carboxyl amino acids are the main determinants for RhoB prenylation and described an anti-farnesyl cysteine antibody as a useful tool for understanding the cellular control of protein farnesylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027361      PMCID: PMC17251          DOI: 10.1073/pnas.97.21.11626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Efficient interaction with a receptor requires a specific type of prenyl group on the G protein gamma subunit.

Authors:  O Kisselev; M Ermolaeva; N Gautam
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

2.  G protein gamma subunits with altered prenylation sequences are properly modified when expressed in Sf9 cells.

Authors:  M A Lindorfer; N E Sherman; K A Woodfork; J E Fletcher; D F Hunt; J C Garrison
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

Review 3.  Protein prenyltransferases.

Authors:  P J Casey; M C Seabra
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

4.  Inhibition of GTP gamma S-dependent phospholipase D and Rho membrane association by calphostin is independent of protein kinase C catalytic activity.

Authors:  G R Dubyak; S B Kertesy
Journal:  Arch Biochem Biophys       Date:  1997-05-01       Impact factor: 4.013

5.  Regions outside of the CAAX motif influence the specificity of prenylation of G protein gamma subunits.

Authors:  V K Kalman; R A Erdman; W A Maltese; J D Robishaw
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

6.  CAAX geranylgeranyl transferase transfers farnesyl as efficiently as geranylgeranyl to RhoB.

Authors:  S A Armstrong; V C Hannah; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1995-04-07       Impact factor: 5.157

7.  Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.

Authors:  W Du; P F Lebowitz; G C Prendergast
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

8.  Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells.

Authors:  G L James; M S Brown; M H Cobb; J L Goldstein
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

Review 9.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

10.  Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.

Authors:  J M Carboni; N Yan; A D Cox; X Bustelo; S M Graham; M J Lynch; R Weinmann; B R Seizinger; C J Der; M Barbacid
Journal:  Oncogene       Date:  1995-05-18       Impact factor: 9.867

View more
  22 in total

1.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

2.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

3.  Analysis of the eukaryotic prenylome by isoprenoid affinity tagging.

Authors:  Uyen T T Nguyen; Zhong Guo; Christine Delon; Yaowen Wu; Celine Deraeve; Benjamin Fränzel; Robin S Bon; Wulf Blankenfeldt; Roger S Goody; Herbert Waldmann; Dirk Wolters; Kirill Alexandrov
Journal:  Nat Chem Biol       Date:  2009-02-15       Impact factor: 15.040

4.  Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.

Authors:  Zhihua Liu; Robin K Meray; Tom N Grammatopoulos; Ross A Fredenburg; Mark R Cookson; Yichin Liu; Todd Logan; Peter T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

Review 5.  Protein prenylation and synaptic plasticity: implications for Alzheimer's disease.

Authors:  David A Hottman; Ling Li
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

6.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

Review 7.  The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease.

Authors:  Yue Zhao; Tian-Yu Wu; Meng-Fei Zhao; Chao-Jun Li
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

8.  Prenylation of Saccharomyces cerevisiae Chs4p Affects Chitin Synthase III activity and chitin chain length.

Authors:  Kariona A Grabińska; Paula Magnelli; Phillips W Robbins
Journal:  Eukaryot Cell       Date:  2006-12-01

9.  Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates.

Authors:  Amanda J Krzysiak; Animesh V Aditya; James L Hougland; Carol A Fierke; Richard A Gibbs
Journal:  Bioorg Med Chem Lett       Date:  2009-11-12       Impact factor: 2.823

10.  ROCK I-mediated activation of NF-kappaB by RhoB.

Authors:  Pedro L Rodriguez; Sutapa Sahay; Oyenike O Olabisi; Ian P Whitehead
Journal:  Cell Signal       Date:  2007-08-08       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.